var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('5/3 - 10:46 PM \; \; | \n'); } if (allow) { document.write('AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. - AKRO | \n'); } if (allow) { document.write('
5/3 - 11:01 AM \; \; | \n'); } if (allow) { document.write('Akero Therapeutics (AKRO) Slides After Failed Trial, Hit With Class Action Lawsuit - Hagens Berman | \n'); } if (allow) { document.write('
5/3 - 10:00 AM \; \; | \n'); } if (allow) { document.write('Glancy Prongay &\; Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors | \n'); } if (allow) { document.write('
5/3 - 6:01 AM \; \; | \n'); } if (allow) { document.write('AKRO INVESTOR ALERT: Bronstein, Gewirtz &\; Grossman LLC Announces that Akero Therapeutics, Inc. Investors Can Join the Class Action Lawsuit! | \n'); } if (allow) { document.write('
5/2 - 10:51 PM \; \; | \n'); } if (allow) { document.write('AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK &\; FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. - AKRO | \n'); } if (allow) { document.write('
5/2 - 9:29 PM \; \; | \n'); } if (allow) { document.write('Akero Therapeutics, Inc. (AKRO) Investor Notice: Robbins LLP Reminds Stockholders of the Akero Therapeutics, Inc. Class Action | \n'); } if (allow) { document.write('
5/2 - 5:31 PM \; \; | \n'); } if (allow) { document.write('INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors | \n'); } if (allow) { document.write('
5/2 - 4:01 PM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with Losses to Contact the Firm | \n'); } if (allow) { document.write('
5/2 - 3:59 PM \; \; | \n'); } if (allow) { document.write('AKRO INVESTOR ALERT: Robbins Geller Rudman &\; Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit | \n'); } if (allow) { document.write('
5/2 - 2:47 PM \; \; | \n'); } if (allow) { document.write('The Law Offices of Frank R. Cruz Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors | \n'); } if (allow) { document.write('
5/2 - 11:21 AM \; \; | \n'); } if (allow) { document.write('Class Action Announcement for Akero Therapeutics, Inc. (AKRO): A Securities Class Action Lawsuit Has Been Filed Against Akero Therapeutics, Inc. | \n'); } if (allow) { document.write('
5/2 - 7:31 AM \; \; | \n'); } if (allow) { document.write('Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc. | \n'); } if (allow) { document.write('
5/2 - 6:01 AM \; \; | \n'); } if (allow) { document.write('AKRO INVESTOR ALERT: Bronstein, Gewirtz &\; Grossman LLC Announces that Akero Therapeutics, Inc. Investors Can Join the Class Action Lawsuit! | \n'); } if (allow) { document.write('
5/1 - 9:42 PM \; \; | \n'); } if (allow) { document.write('AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | \n'); } if (allow) { document.write('
5/1 - 9:21 PM \; \; | \n'); } if (allow) { document.write('AKRO INVESTOR ALERT: Bronstein, Gewirtz &\; Grossman LLC Announces that Akero Therapeutics, Inc. Investors Can Join the Class Action Lawsuit! | \n'); } if (allow) { document.write('
5/1 - 1:06 PM \; \; | \n'); } if (allow) { document.write('DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with Losses to Contact the Firm | \n'); } if (allow) { document.write('
5/1 - 11:16 AM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm | \n'); } if (allow) { document.write('
5/1 - 9:16 AM \; \; | \n'); } if (allow) { document.write('NASDAQ: AKRO: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Akero Therapeutics, Inc. | \n'); } if (allow) { document.write('
5/1 - 8:57 AM \; \; | \n'); } if (allow) { document.write('Grabar Law Office Investigates Claims on Behalf of Shareholders of Akero Therapeutics, Inc. (AKRO) | \n'); } if (allow) { document.write('
4/30 - 10:35 PM \; \; | \n'); } if (allow) { document.write('NASDAQ: AKRO: Kessler Topaz Meltzer &\; Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Akero Therapeutics, Inc. | \n'); } if (allow) { document.write('
more news | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' |